Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruzinurad vs Allopurinol in Gout
NCT04956432Phase 3Completed
- Sponsor
- Hengrui
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ruzinurad in gout, sponsored by Hengrui. Started Jun 2021; status: completed.
02
Drugs
ruzinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT04956432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04956432.